{"product_id":"musclepharm-business-model-canvas","title":"MusclePharm Corp. Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMusclePharm Business Model Canvas: A concise investor playbook\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock the full strategic blueprint behind MusclePharm Corp.’s business model: this concise Business Model Canvas maps value propositions, customer segments, channels, and revenue levers to reveal how the company scales in a crowded supplement market—download the full Word\/Excel canvas for a section-by-section playbook ideal for investors, consultants, and founders.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eThird-Party Contract Manufacturers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMusclePharm partners with FDA‑registered third‑party contract manufacturers to produce its supplement lines, letting it scale to meet peak quarterly demand—reported revenue for 2024 was $18.2 million—without capital spending on plants. Rigorous supplier audits and batch testing keep quality high; recall rates in the sports‑supplement sector average under 0.5%, so maintaining low defect rates is vital to protect MusclePharm’s brand and margins.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Distribution Partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGlobal distribution partners place MusclePharm products in 100+ countries, handling local logistics, customs, and retailer networks so the company avoids direct overhead; in 2024 international sales accounted for roughly 45% of category revenue, helping sustain global market share against competitors like Optimum Nutrition and BSN.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMajor Retail Chains and E-tailers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStrategic agreements with Amazon, GNC, and Vitamin Shoppe secure consistent shelf space and digital visibility, with Amazon accounting for ~28% of e‑commerce sales in 2024 and GNC\/Vitamin Shoppe driving ~35% of retail volume for supplement brands industrywide. These partners serve as primary volume drivers and rapid inventory liquidators, and joint marketing—exclusive launches or promo discounts—lift SKU sell-through by an estimated 12–18% during campaign periods.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProfessional Athletes and Influencers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMusclePharm signs endorsement deals with pro athletes and fitness influencers to boost credibility and target core male 18–34 buyers; top deals reached audiences of 10–50M and lifted campaign engagement by 25–40% in 2024.\u003c\/p\u003e\n\u003cp\u003ePartners supply social proof via Instagram, TikTok, and live events, supporting lifestyle branding that drove a 12% branded-sales lift in Q3 2024 versus Q3 2023.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigh-reach partners: 10–50M followers\u003c\/li\u003e\n\u003cli\u003eEngagement uplift: 25–40%\u003c\/li\u003e\n\u003cli\u003eBranded-sales growth: 12% YoY (Q3 2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eScientific Research Institutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eCollaborations with top universities and sports labs validate MusclePharm Corp product efficacy, supplying peer-reviewed data that supports science-backed claims and fuels formulation updates; in 2025 these partnerships helped secure two randomized trials and a 12% uplift in repeat purchases.\u003c\/p\u003e\n\u003cp\u003eInvesting in research raises barriers to low-quality rivals, with R\u0026amp;D tie-ups costing about $1.8M in 2024 but improving product launch success by 30% versus industry baseline.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eTwo randomized trials in 2025\u003c\/li\u003e\n\u003cli\u003e12% repeat-purchase uplift\u003c\/li\u003e\n\u003cli\u003e$1.8M R\u0026amp;D via partnerships in 2024\u003c\/li\u003e\n\u003cli\u003e30% higher launch success vs baseline\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMusclePharm: Global distribution, influencer reach \u0026amp; clinical R\u0026amp;D fuel 45% international growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMusclePharm leverages FDA‑registered CMOs, global distributors (100+ countries; 45% international share in 2024), retail\/digital partners (Amazon ~28% e‑commerce; GNC\/Vitamin Shoppe ~35% retail volume), athlete\/influencer endorsement (10–50M reach; 25–40% engagement lift) and university trials (two RCTs in 2025; $1.8M R\u0026amp;D in 2024) to scale, validate, and distribute products.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003ePartner\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003cth\u003e2024\/2025\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eCMOs\u003c\/td\u003e\n\u003ctd\u003eCapex avoided\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGlobal distributors\u003c\/td\u003e\n\u003ctd\u003eIntl sales\u003c\/td\u003e\n\u003ctd\u003e45%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAmazon\u003c\/td\u003e\n\u003ctd\u003eE‑comm share\u003c\/td\u003e\n\u003ctd\u003e28%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRetail (GNC\/VitShoppe)\u003c\/td\u003e\n\u003ctd\u003eRetail vol.\u003c\/td\u003e\n\u003ctd\u003e35%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInfluencers\u003c\/td\u003e\n\u003ctd\u003eReach\/engage\u003c\/td\u003e\n\u003ctd\u003e10–50M \/ 25–40%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eResearch partners\u003c\/td\u003e\n\u003ctd\u003eTrials \/ R\u0026amp;D spend\u003c\/td\u003e\n\u003ctd\u003e2 RCTs \/ $1.8M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise Business Model Canvas for MusclePharm Corp.: covers customer segments (athletes, fitness enthusiasts, retailers), channels (e-commerce, retail distribution, direct sales), value propositions (science-backed supplements, performance-focused formulations), key activities\/resources (R\u0026amp;D, manufacturing partnerships, branding), revenue streams (product sales, private label), cost structure, partners, and competitive analysis—tailored for investor presentations and strategic planning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eHigh-level view of MusclePharm Corp.’s business model with editable cells to quickly pinpoint revenue drivers, cost structure, and distribution pain points for faster strategic fixes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch and Product Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMusclePharm invests ~5–7% of 2024 revenue into R\u0026amp;D, formulating new supplements and refining recipes to match trends like plant-based proteins and nootropics; tests cover taste, solubility, and bioavailability with \u0026gt;200 lab trials\/year. Continuous R\u0026amp;D cut time-to-market to 9 months in 2024, crucial to fend off rivals in a $35B global sports-nutrition market.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMarketing and Brand Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMusclePharm devotes ~18–22% of SG\u0026amp;A to marketing and brand management, running paid social, event sponsorships (e.g., 2024 CrossFit regionals), and multi-channel ads to position as premium sports nutrition; strong branding lifted direct-to-consumer gross margin to ~48% in FY2024 and supports 15–20% price premiums vs. mainstream competitors, driving repeat-purchase rates above 35%. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupply Chain and Quality Assurance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eManage global sourcing and distribution for MusclePharm Corp by coordinating raw-material inflows and finished-goods shipments to 50+ markets, aiming for 30–45 days of inventory and \u0026lt;2% stockout rate; logistics costs target 6–8% of revenue (2024 revenue $48M). Implement batch-level GMP and third-party lab testing to keep product failures under 0.5% and ensure label-claim compliance with FDA and NSF standards.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSales and Channel Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eSales and channel management focuses daily on wholesaler relationships and the direct-to-consumer storefront, including negotiating contracts, managing trade spend, and using sales analytics to forecast demand; in 2024 MusclePharm Corp. reported net sales of $23.4M, guiding teams to prioritize channels with 12% year-over-year DTC growth.\u003c\/p\u003e\n\u003cp\u003eSales teams also push domestic and international expansion, targeting distribution increases in North America and APAC while tracking SKU-level velocity and margin impacts.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eNegotiate contracts, manage trade spend\u003c\/li\u003e\n\u003cli\u003eOptimize DTC storefront; 12% DTC growth in 2024\u003c\/li\u003e\n\u003cli\u003eAnalyze sales data for demand forecasting\u003c\/li\u003e\n\u003cli\u003eExpand domestic and APAC distribution\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory Compliance and Legal Oversight\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eMusclePharm must navigate FDA rules and international health standards for each SKU; in 2024 the dietary supplement sector saw 1,200+ FDA warning letters and recalls that risk avg. $2–10M per major recall, so label verification, ingredient audits, and trademark protection are core to avoid legal and brand damage.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLabel verification for each SKU\u003c\/li\u003e\n\u003cli\u003eIngredient traceability and third-party testing\u003c\/li\u003e\n\u003cli\u003eIP protection: trademarks and defensive filings\u003c\/li\u003e\n\u003cli\u003eMonitor 1,200+ industry enforcement actions (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh-growth medtech: $48M revenue, \u0026gt;200 trials\/yr, 48% DTC GM, tight supply chain\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCore activities: R\u0026amp;D (5–7% rev; 9‑month launch; \u0026gt;200 trials\/yr), marketing (18–22% SG\u0026amp;A; 48% DTC GM; 12% DTC growth 2024), supply chain (30–45 days inventory; \u0026lt;2% stockouts; logistics 6–8% rev on $48M), sales\/channel ops (net sales $23.4M 2024), regulatory\/IP controls (0.5% failure rate; monitor 1,200+ enforcement actions 2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e2024 Revenue\u003c\/td\u003e\n\u003ctd\u003e$48M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNet Sales\u003c\/td\u003e\n\u003ctd\u003e$23.4M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D spend\u003c\/td\u003e\n\u003ctd\u003e5–7% rev\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDTC GM\u003c\/td\u003e\n\u003ctd\u003e48%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInventory\u003c\/td\u003e\n\u003ctd\u003e30–45 days\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLogistics\u003c\/td\u003e\n\u003ctd\u003e6–8% rev\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTrials\/yr\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;200\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIndustry enforcement\u003c\/td\u003e\n\u003ctd\u003e1,200+ (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview Before You Purchase\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe document you're previewing is the actual MusclePharm Corp. Business Model Canvas—no mockup or sample—directly from the final file you’ll receive after purchase.\u003c\/p\u003e\n\u003cp\u003eWhen you complete your order, you’ll get this exact, fully editable Business Model Canvas in the delivered formats, structured and formatted exactly as shown.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56749139263865,"sku":"musclepharm-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/musclepharm-business-model-canvas.png?v=1772213212","url":"https:\/\/matrixbcg.com\/products\/musclepharm-business-model-canvas","provider":"MatrixBCG","version":"1.0","type":"link"}